PRESS RELEASE
News
-
-
PRESS RELEASE
EQS-Adhoc: Formycon resolves on cash capital increase of EUR 82.84 million – all new shares were subscribed by Gedeon Richter as new strategic investor
Formycon AG resolves on EUR 82.84 million cash capital increase by issuing 1,603,877 new shares, all subscribed by Gedeon Richter as strategic investor. Proceeds for biosimilar pipeline development. New shares to be traded on Frankfurt Stock Exchange -
PRESS RELEASE
America's Best Dentist is Now Serving Fountain Valley in Cosmetic Dentistry as KYT Dental Services
Dr. Isaac Sun of KYT Dental Services in Fountain Valley, CA, is offering free Invisalign whitening trays for Orange County patients, highlighting the benefits and authenticity of Invisalign treatment. Dr. Sun, a top-tier cosmetic dentist, prioritizes patient-centered orthodontic care and advocates for transparency and authenticity in Invisalign treatment -
-
PRESS RELEASE
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages BioVie Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BIVI
Rosen Law Firm, a global investor rights law firm, reminds purchasers of BioVie Inc. (NASDAQ: BIVI) securities of the important March 19, 2024 lead plaintiff deadline in securities class action. Investors may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement -
-
PRESS RELEASE
Westwing Group SE Trading Update: Westwing continued with profitable growth in Q4 2023 and confirms updated FY 2023 guidance
Westwing Group SE reports profitable growth in Q4 2023 and confirms updated FY 2023 guidance. GMV reached EUR 147 million in Q4 with a +4% increase year-over-year. Adjusted EBITDA expected in upper half of the updated FY 2023 guidance -
PRESS RELEASE
ROSEN, A LEADING LAW FIRM, Encourages AlloVir, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
Rosen Law Firm urges AlloVir, Inc. investors with losses during Mar 22, 2022 - Dec 21, 2023, to seek counsel before Mar 19, 2024, for securities class action (NASDAQ: ALVR). Details indicate false and misleading statements made by AlloVir -
-
